← Leaderboards
Hemant K Roy
Northshore Univ Healthsystem Res Inst
$18,742,267
Attributed
$36,521,962
Total exposure
18
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,521,962 · 18
By mechanism
R01$24,282,438 · 9
U01$5,962,370 · 1
R42$2,649,660 · 2
R21$1,867,280 · 4
R33$1,586,214 · 1
R03$174,000 · 1
Top collaborators
- Vadim Backman57 shared
- Hariharan Subramanian6 shared
- Igal G Szleifer6 shared
- Jeremy D. Rogers5 shared
- Susan E. Crawford4 shared
- Arpan Mohanty2 shared
- Ramesh K Wali2 shared
- Charles Brendler1 shared
Others in their field
Top investigators on “Carcinogenesis”
- Thomas James Lynch · Fred Hutchinson Cancer Center$52,622,533
- John Anthony Baron · Dartmouth College$42,903,133
- Judith Cheryl Gasson · University Of California Los Angeles$27,647,316
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$27,566,264
- Frank Louis Meyskens · University Of California Irvine$27,314,067
- Paul F Lambert · University Of Wisconsin Madison$25,295,170
Research focus
CarcinogenesisCessation Of LifeMalignant NeoplasmsCancer EtiologyTechnologyMucous MembraneBaseAmericanBiophotonicsColorectal CancerOpticsColonDetectionAdenomaGeneticLesionCostProceduresNeoplasmsGenderColonoscopyMolecularCellsFuture
Grant awards (73)
Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification$670,534
R01 · FY2025 · CA
Translating buccal nanocytology for lung cancer screening into clinical practice$311,097
R01 · FY2023 · CA
Translating buccal nanocytology for lung cancer screening into clinical practice$671,131
R01 · FY2022 · CA
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications$613,159
R01 · FY2022 · CA · contact PI
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure$607,121
R01 · FY2022 · CA
Unraveling Racial Disparities in Portal Hypertension: A Clinical, Spectroscopic andSNP Approach$243,822
R21 · FY2022 · MD · contact PI
Translating buccal nanocytology for lung cancer screening into clinical practice$673,514
R01 · FY2021 · CA
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure$632,115
R01 · FY2021 · CA
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications$631,604
R01 · FY2021 · CA · contact PI
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications$683,687
R01 · FY2020 · CA · contact PI
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure$636,330
R01 · FY2020 · CA
Unraveling Racial Disparities in Portal Hypertension: A Clinical, Spectroscopic and SNP Approach$226,232
R21 · FY2020 · MD · contact PI
Translating buccal nanocytology for lung cancer screening into clinical practice$123,567
R01 · FY2020 · CA
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications$669,582
R01 · FY2019 · CA · contact PI
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure$621,362
R01 · FY2019 · CA
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology$603,868
R01 · FY2019 · CA
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy$598,589
R01 · FY2019 · CA
Translating buccal nanocytology for lung cancer screening into clinical practice$587,752
R01 · FY2019 · CA
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications$715,647
R01 · FY2018 · CA · contact PI
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure$659,504
R01 · FY2018 · CA
Translating buccal nanocytology for lung cancer screening into clinical practice$638,469
R01 · FY2018 · CA
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology$628,861
R01 · FY2018 · CA
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy$620,486
R01 · FY2018 · CA
Area B: Minimally Intrusive Colorectal Cancer Risk Stratification with Nanocytology: Targeting Underscreened Populations$1,070,208
R33 · FY2017 · CA · contact PI
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy$634,023
R01 · FY2017 · CA
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology$633,774
R01 · FY2017 · CA
Area B: Minimally Intrusive Colorectal Cancer Risk Stratification with Nanocytology:Targeting Underscreened Populations$516,006
R33 · FY2017 · CA · contact PI
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy$645,565
R01 · FY2016 · CA
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology$621,871
R01 · FY2016 · CA
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer Screening$543,723
R01 · FY2016 · CA
Towards Development of an in vitro Assay to Personalize Colonic Chemoprevention$87,000
R03 · FY2016 · CA · contact PI
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy$684,278
R01 · FY2015 · CA
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology$652,533
R01 · FY2015 · CA
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer Screening$556,786
R01 · FY2015 · CA
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers$522,033
R01 · FY2015 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$190,284
U01 · FY2015 · CA · contact PI
Towards Development of an in vitro Assay to Personalize Colonic Chemoprevention$87,000
R03 · FY2015 · CA · contact PI
Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance$769,287
R42 · FY2014 · CA · contact PI
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer Screening$548,368
R01 · FY2014 · CA
Spectral Markers for Early Detection of Colon Neoplasia$543,670
U01 · FY2014 · CA · contact PI
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening$527,979
R01 · FY2014 · CA
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers$522,335
R01 · FY2014 · CA · contact PI
Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance$739,285
R42 · FY2013 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$541,643
U01 · FY2013 · CA · contact PI
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer Screening$538,843
R01 · FY2013 · CA
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening$533,083
R01 · FY2013 · CA
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers$463,445
R01 · FY2013 · CA · contact PI
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers$72,469
R01 · FY2013 · CA · contact PI
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer Screening$607,847
R01 · FY2012 · CA
Spectral Markers for Early Detection of Colon Neoplasia$602,303
U01 · FY2012 · CA · contact PI
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening$590,916
R01 · FY2012 · CA
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers$559,582
R01 · FY2012 · CA · contact PI
Biophotonics Noninvasive Detection of Ovarian Cancer$316,438
R21 · FY2012 · CA
Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance$300,000
R42 · FY2012 · CA · contact PI
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers$619,689
R01 · FY2011 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$610,966
U01 · FY2011 · CA · contact PI
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening$605,317
R01 · FY2011 · CA
Biophotonics Noninvasive Detection of Ovarian Cancer$329,563
R21 · FY2011 · CA
Spectral Markers for Early Detection of Colon Neoplasia$152,700
U01 · FY2011 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$639,759
U01 · FY2010 · CA · contact PI
Improving Flexible Sigmoidoscopy in Women by Optical Analysis of Microvasculature$167,750
R21 · FY2010 · CA · contact PI
Gender Selectivity to Colon Cancer Chemoprevention by NSAIDS$167,750
R21 · FY2010 · CA
Spectral Markers for Early Detection of Colon Neoplasia$359,062
U01 · FY2009 · CA · contact PI
Improving colonoscopic miss rate by real time microvascular blood analysis$346,336
R42 · FY2009 · CA · contact PI
Improving Flexible Sigmoidoscopy in Women by Optical Analysis of Microvasculature$214,425
R21 · FY2009 · CA · contact PI
Gender Selectivity to Colon Cancer Chemoprevention by NSAIDS$201,300
R21 · FY2009 · CA
Spectral Markers for Early Detection of Colon Neoplasia$489,631
U01 · FY2008 · CA · contact PI
Improving colonoscopic miss rate by real time microvascular blood analysis$394,745
R42 · FY2008 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$478,908
U01 · FY2007 · CA · contact PI
Improving colonoscopic miss rate by real time microvascular blood analysis$100,007
R42 · FY2007 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$492,336
U01 · FY2006 · CA · contact PI
Spectral Markers for Early Detection of Colon Neoplasia$493,361
U01 · FY2005 · CA
Spectral Markers for Early Detection of Colon Neoplasia$367,747
U01 · FY2004 · CA